Online citations, reference lists, and bibliographies.
← Back to Search

Management Of Malignant Pleural Effusion

J. Kastelik
Published 2012 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Malignancy is one of the most common causes of pleural effusion. Malignant pleural effusion is defined by the presence of malignant cells in the pleural fluid. Development of malignant pleural effusion usually defines advanced malignancy. Pathophysiology of malignant pleural effusion is not fully understood and may involve complex interactions between the mesothelial and malignant cells. Investigations and management of patients with malignant pleural effusion require a multidisciplinary approach. In this review, current practice for management of patients with malignant pleural effusion will be discussed. In addition, imaging techniques will be covered, including the use of thoracic ultrasound and its role in image-guiding pleural procedures. Moreover, interventional techniques will be described, such as medical thoracoscopy, the use of indwelling pleural catheters, or surgery for investigation and management of malignant pleural effusion.
This paper references
10.1159/000335419
Mechanisms of Pleurodesis
F. Rodríguez-Panadero (2012)
10.1001/jama.2012.5535
Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial.
H. E. Davies (2012)
10.1164/ARRD.1986.133.4.658
The relationship between pleural pressures and changes in pulmonary function after therapeutic thoracentesis.
R. Light (1986)
10.1177/030089161009600308
Metastatic Breast Cancer Shows Different Immunohistochemical Phenotype According to Metastatic Site
J. Koo (2010)
10.1164/AJRCCM/151.3_PT_1.785
Failure of talc pleurodesis is associated with increased pleural fibrinolysis.
F. Rodríguez-Panadero (1995)
10.4997/JRCPE.2010.206
The utility of pleural amylase measurement in metastatic mucinous adenocarcinoma.
A. Fahim (2010)
10.1136/thx.2010.137026
Pleural procedures and thoracic ultrasound: British Thoracic Society pleural disease guideline 2010
T. Havelock (2010)
10.1016/S0272-5231(05)70081-2
Pleural disease in patients with acquired immune deficiency syndrome.
J. M. Beck (1998)
10.1016/0002-9343(83)91072-0
Mechanism of relief of dyspnea after thoracocentesis in patients with large pleural effusions.
M. Estenne (1983)
10.1111/j.1440-1843.2011.02100.x
Getting the most from pleural fluid analysis
Steven A. Sahn (2012)
10.1055/S-2007-1009846
Pulmonary Physiologic Abnormalities Caused by Pleural Disease
M. Judson (1995)
10.1155/2012/806183
Role of Talc Modulation on Cytokine Activation in Cancer Patients Undergoing Pleurodesis
Y. Schwarz (2012)
10.1378/CHEST.67.5.536
Efficacy of pleural needle biopsy and pleural fluid cytopathology in the diagnosis of malignant neoplasm involving the pleura.
W. Salyer (1975)
10.1159/000324266
New Challenges in Medical Thoracoscopy
M. Froudarakis (2011)
10.1159/000158545
Medical thoracoscopy.
F. Rodríguez-Panadero (2008)
10.1046/j.1440-1843.1999.00155.x
Video‐assisted thoracic surgery: A renaissance in surgical therapy
A. Yim (1999)
10.1016/J.LUNGCAN.2006.06.004
Efficacy of short-term versus long-term chest tube drainage following talc slurry pleurodesis in patients with malignant pleural effusions: a randomised trial.
Anna Goodman (2006)
Efficacy of short-term versus long-term chest tube drainage following talc slurry pleurodesis in patients with malignant pleural effusions: a randomised trial. Lung Cancer
A Goodman (2006)
10.1378/CHEST.122.5.1737
Distribution of calibrated talc after intrapleural administration: an experimental study in rats.
A. Fraticelli (2002)
10.4065/83.2.235
Recent advances in the diagnosis and management of malignant pleural effusions.
J. Heffner (2008)
10.1016/S1556-0864(15)30365-8
Solitary fibrous tumor of the pleura with associated hypoglycemia: Doege-Potter syndrome: a case report.
B. Balduyck (2006)
10.1378/CHEST.117.1.73
Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease.
C. Burrows (2000)
10.2214/AJR.175.1.1750245
FDG PET of pleural effusions in patients with non-small cell lung cancer.
J. Erasmus (2000)
10.6004/JNCCN.2012.0102
Optimal management of malignant pleural effusions (results of CALGB 30102).
T. Demmy (2012)
10.1378/CHEST.123.2.418
Ultrasound-guided thoracentesis: is it a safer method?
P. W. Jones (2003)
10.1158/1078-0432.CCR-10-1929
Serum Soluble Mesothelin Concentrations in Malignant Pleural Mesothelioma: Relationship to Tumor Volume, Clinical Stage and Changes in Tumor Burden
J. Creaney (2010)
10.1002/jhm.981
Contarini's syndrome: bilateral pleural effusion, each side from different causes.
J. M. Porcel (2012)
10.1159/000029522
Malignant Transient Pleural Transudate: A Sign of Early Lymphatic Tumoral Obstruction
C. Fernández (2000)
10.1378/CHEST.06-0430
Characteristics of trapped lung: pleural fluid analysis, manometry, and air-contrast chest CT.
J. T. Huggins (2007)
10.1136/thx.2009.133504
Chemotherapy should not be withheld from patients with an indwelling pleural catheter for malignant pleural effusion
A. Morel (2010)
10.1097/JTO.0b013e31823e0667
Pleural Fluid Cytological Yield and Visceral Pleural Invasion in Patients with Epithelioid Malignant Pleural Mesothelioma
V. Pinelli (2012)
10.1378/CHEST.74.6.679
"Contarini's condition:" bilateral pleural effusions with markedly different characteristics.
C. P. Kutty (1978)
10.1093/AJCP/73.2.289A
Comparison of the diagnostic values of pleural biopsies and cytologic evaluation of pleural fluids.
W. Salyer (1980)
10.1093/AJCP/70.6.855
Cytology of serous effusions. An investigation into the usefulness of cell blocks versus smears.
A. Dekker (1978)
10.1016/S0025-6196(12)60212-2
Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases.
U. Prakash (1985)
10.3310/HTA11260
Hormonal therapies for early breast cancer: systematic review and economic evaluation.
D. Hind (2007)
10.1016/S0012-3692(15)51155-0
Pathophysiology of pneumothorax following ultrasound-guided thoracentesis.
J. Heidecker (2006)
10.1016/S1470-2045(11)70149-8
Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study
T. Treasure (2011)
10.1007/978-0-387-74039-3_1
Overview of resistance to systemic therapy in patients with breast cancer.
A. González-Angulo (2007)
10.7170/JSIS.V1I3.429
Clinical and pathological factors influencing the survival of breast cancer patients with malignant pleural effusion.
Giovana Santos (2012)
10.1038/cgt.2012.36
Management of malignant pleural effusion by suicide gene therapy in advanced stage lung cancer: a case series and literature review
P. Zarogoulidis (2012)
10.1016/J.ARBRES.2011.06.011
Derrames pleurales eosinofílicos: incidencia, etiología y significado pronóstico
L. Ferreiro (2011)
10.1007/s11606-010-1472-0
Efficacy and Safety of Tunneled Pleural Catheters in Adults with Malignant Pleural Effusions: A Systematic Review
Margaret E. M. Van Meter (2010)
10.1016/j.rmed.2009.08.010
Chylothorax: aetiology, diagnosis and therapeutic options.
E. Mcgrath (2010)
10.12968/HMED.2011.72.6.331
Pleural procedures: intercostal chest drains and indwelling pleural catheters.
Anna C. Bibby (2011)
10.1590/S1806-37132012000400011
Fatores clínicos e anatomopatológicos que influenciam a sobrevida de pacientes com câncer de mama e derrame pleural neoplásico
Giovana Tavares dos Santos (2012)
10.1007/s00259-005-0059-1
Malignant mesothelioma of the peritoneum as the cause of a paraneoplastic syndrome: detection by 18F-FDG PET
S. Banayan (2005)
New challenges in medical thoracoscopy. Respiration
ME Froudarakis (2011)
10.1016/S0140-6736(07)60708-9
Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study
J. Janssen (2007)
10.1016/j.jtcvs.2007.10.054
Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.
R. Flores (2008)
[Pleural effusions].
G. Pescetti (1965)
10.1159/000243553
Medical Thoracoscopy: New Tricks for an Old Trade
M. Froudarakis (2009)
10.1002/jso.22100
Multidisciplinary management of malignant pleural effusion
J. Kaifi (2012)
10.1378/CHEST.123.6.1895
Rapid pleurodesis for malignant pleural effusions.
P. Spiegler (2003)
Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients
平田 泰三 (2011)
10.1097/RTI.0b013e3182128704
Positron Emission Tomography/Computed Tomography in Lung Cancer Staging, Prognosis, and Assessment of Therapeutic Response
M. Truong (2011)
10.1016/j.lungcan.2012.03.006
VEGF and sVEGFR-1 in malignant pleural effusions: association with survival and pleurodesis outcomes.
C. E. Hooper (2012)
10.1111/j.1440-1843.2007.01144.x
Prospective evaluation of flex‐rigid pleuroscopy for indeterminate pleural effusion: Accuracy, safety and outcome
P. Lee (2007)
10.1097/JTO.0b013e318267223a
Prognostic Impact of Malignant Pleural Effusion at Presentation in Patients with Metastatic Non–Small-Cell Lung Cancer
D. Morgensztern (2012)
10.1002/(SICI)1097-0142(19991115)86:10<1992::AID-CNCR16>3.0.CO;2-M
A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions
J. Putnam (1999)
10.1002/JCU.20163
Sonographically guided thoracentesis and rate of pneumothorax
Terrance W. Barnes (2005)
10.1378/chest.07-2232
Pleural fluid analysis in chylous pleural effusion.
V. Agrawal (2008)
10.1053/j.semtcvs.2009.06.008
Surgical options in malignant pleural mesothelioma: extrapleural pneumonectomy or pleurectomy/decortication.
R. Flores (2009)
10.1177/030089160809400314
Factors Predictive of Response to Hormone Therapy in Breast Cancer
F. Rastelli (2008)
10.1164/rccm.200801-062OC
Clinically important factors influencing the diagnostic measurement of pleural fluid pH and glucose.
N. Rahman (2008)
10.1093/jjco/hys099
Gemcitabine-induced pleuropericardial effusion in a patient with pancreatic cancer.
Hidenori Kido (2012)
10.1378/chest.10-1868
Rapid pleurodesis for malignant pleural effusions: a pilot study.
C. Reddy (2011)
10.1007/978-3-642-10862-4_3
Imaging of mesothelioma.
R. Gill (2011)
10.1378/chest.11-0348
Thoracic ultrasonography for the pulmonary specialist.
S. Koenig (2011)
10.1378/CHEST.117.4.1031
Pleural effusion and pneumothorax in hospitalized patients with HIV infection: the Pulmonary Complications, ICU support, and Prognostic Factors of Hospitalized Patients with HIV (PIP) Study.
B. Afessa (2000)
10.1378/CHEST.95.2.320
Survival time of patients with pleural metastatic carcinoma predicted by glucose and pH studies.
F. Rodríguez-Panadero (1989)
10.1378/CHEST.90.1.97
Complications associated with thoracocentesis.
M. Seneff (1986)
10.1136/thx.2010.137018
Local anaesthetic thoracoscopy: British Thoracic Society pleural disease guideline 2010
N. Rahman (2010)
Practical procedures: chemical pleurodesis—what is it & how to do it
A Gondker (2011)
10.1183/09031936.00.15116600
Diagnostic utility of eosinophils in the pleural fluid.
M. Martinez-Garcia (2000)
10.2214/AJR.166.4.8610582
Usefulness of MR signal intensity in distinguishing benign from malignant pleural disease.
F. Falaschi (1996)
10.1097/MCP.0b013e32832b98eb
Serum and pleural fluid biomarkers for mesothelioma
J. Creaney (2009)
10.1378/chest.09-0641
Prospective study to determine the volume of pleural fluid required to diagnose malignancy.
J. Swiderek (2010)
10.1016/j.critrevonc.2011.01.010
Treatment of metastatic breast cancer: state-of-the-art, subtypes and perspectives.
N. E. El Saghir (2011)
10.1164/rccm.200811-1729OC
Clinical impact and reliability of pleural fluid mesothelin in undiagnosed pleural effusions.
H. E. Davies (2009)
Co-existent chylous and serous pleural effusions associated with ovarian cancer: a case report of Contarini's syndrome.
F. Lawton (1985)
10.1183/09031936.00101706
The autoclavable semirigid thoracoscope: the way forward in pleural disease?
M. Munavvar (2007)
10.1378/CHEST.124.5.1975
Minithoracoscopy: a less invasive approach to thoracoscopy.
G. Tassi (2003)
10.1183/09031936.00164706
Use of tunnelled catheters for malignant pleural effusions in patients fit for pleurodesis
A. Tremblay (2007)
10.1111/j.1440-1843.2010.01832.x
Setting up a specialist pleural disease service
C. Hooper (2010)
10.1200/JCO.2011.41.2056
First-line erlotinib followed by second-line cisplatin-gemcitabine chemotherapy in advanced non-small-cell lung cancer: the TORCH randomized trial.
C. Gridelli (2012)
10.1159/000329703
Advanced Malignant Lung Disease: What the Specialist Can Offer
D. Gompelmann (2011)
10.1136/thx.2008.100545
Thoracic ultrasound in the diagnosis of malignant pleural effusion
N. R. Qureshi (2008)
what the specialist can offer
D Gompelmann (2013)
Comparison of the clinical diagnostic value between pleural needle biopsy and analysis of pleural effusion.
N. Chen (1997)
10.1164/ARRD.1978.117.4.789
Mesothelioma associated with the syndrome of inappropriate secretion of antidiuretic hormone.
W. Perks (1978)
10.1093/AJCP/64.2.200
Diagnostic reliability of needle biopsy of the parietal pleura. A review of 272 biopsies.
D. V. Von Hoff (1975)
10.1634/theoncologist.2011-S1-71
Directed therapy of subtypes of triple-negative breast cancer.
L. Carey (2011)
10.1097/00063198-200007000-00003
Management of malignant pleural mesothelioma: a critical review
Y. Lee (2000)
10.2214/AJR.154.3.2106209
CT in differential diagnosis of diffuse pleural disease.
A. Leung (1990)
10.1111/j.1440-1843.2004.00599.x
Radiology in pleural disease: State of the art
A. L. Evans (2004)
10.1700/1088.11927
PET scan contribution in chest tumor management: a systematic review for thoracic surgeons.
Leonardo Duranti (2012)
10.1136/thx.2009.128496
Diagnostic accuracy, safety and utilisation of respiratory physician-delivered thoracic ultrasound
N. Rahman (2010)
10.1007/s11864-011-0146-4
The Evolution of Multimodality Therapy for Malignant Pleural Mesothelioma
M. Zauderer (2011)
10.1038/bjc.2011.104
Markers for the non-invasive diagnosis of mesothelioma: a systematic review
S. van der Bij (2011)
10.1136/thx.2009.115378
Thoracic ultrasound: an important skill for respiratory physicians
J. Kastelik (2009)
10.1111/j.1365-2303.2007.00382.x
Cytopathological spectrum of unusual malignant pleural effusions at a tertiary care centre in north India
A. Awasthi (2007)
10.1002/14651858.CD002916.pub3
WITHDRAWN: Pleurodesis for malignant pleural effusions.
P. Shaw (2013)
10.1136/thx.2010.136978
Investigation of a unilateral pleural effusion in adults: British Thoracic Society pleural disease guideline 2010
C. Hooper (2010)
10.1378/CHEST.123.2.551
Surgical treatment of malignant pleural mesothelioma: a review.
S. van Ruth (2003)
10.1378/CHEST.129.2.362
Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion.
A. Tremblay (2006)
10.1164/AJRCCM/139.3.663
Low glucose and pH levels in malignant pleural effusions. Diagnostic significance and prognostic value in respect to pleurodesis.
F. Rodríguez-Panadero (1989)
10.4081/MONALDI.2011.252
Advanced medical thoracoscopy.
G. Tassi (2011)
10.2217/fon.11.45
Diagnostic molecular biomarkers for malignant pleural effusions.
K. Sriram (2011)
10.1097/01.mcp.0000166495.71574.46
Management of malignant pleural effusions
R. Bennett (2005)
10.1097/MCP.0b013e32832b8b2d
Medical thoracoscopy
R. Casal (2009)
10.1055/s-0030-1269831
Management of the patient with a malignant pleural effusion.
J. Heffner (2010)
10.1136/thx.2010.136994
Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010
M. Roberts (2010)
10.1097/00063198-200107000-00007
Pleural effusions and pneumothoraces in AIDS.
B. Afessa (2001)
10.1002/jmri.22372
Imaging of the pleura
E. J. Helm (2010)
10.1016/j.ygyno.2012.02.029
Outcomes of patients with gynecologic malignancies undergoing video-assisted thoracoscopic surgery (VATS) and pleurodesis for malignant pleural effusion.
J. Whitworth (2012)
10.1634/theoncologist.2010-S1-49
Rewarding value creation to promote innovation in oncology: The importance of considering the global product life cycle.
L. Garrison (2010)
10.1043/1543-2165-133.8.1317
Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group.
A. Husain (2009)
10.1183/09031936.00014106
Advanced techniques in medical thoracoscopy
G. Tassi (2006)
10.1378/CHEST.120.6.1798
Percutaneous image-guided cutting needle biopsy of the pleura in the diagnosis of malignant mesothelioma.
R. F. Adams (2001)
10.1016/S0140-6736(04)17108-0
Pleural mesothelioma: little evidence, still time to do trials
T. Treasure (2004)
10.7150/jca.2586
FDG PET/CT Response Evaluation in Malignant Pleural Mesothelioma Patients Treated with Talc Pleurodesis and Chemotherapy
G. Genestreti (2012)
10.4037/ajcc2011685
Diagnosis of pleural effusion: a systematic approach.
E. Mcgrath (2011)
10.1200/JCO.2011.39.6671
Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis.
Kevin Hollevoet (2012)
Clinical utility of a combination of tumour markers in the diagnosis of malignant pleural effusions.
M. J. Gaspar (2008)
10.1378/chest.08-1227
Reducing iatrogenic risk in thoracentesis: establishing best practice via experiential training in a zero-risk environment.
Darlene R Duncan (2009)
10.2147/BTT.S26558
First-line treatment of EGFR-mutant non-small-cell lung cancer: the role of erlotinib and other tyrosine kinase inhibitors
Kim-Son H Nguyen (2012)
10.1016/j.ejim.2008.11.009
High levels of tumor markers in pleural fluid correlate with poor survival in patients with adenocarcinomatous or squamous malignant effusions.
S. Bielsa (2009)
10.1002/14651858.CD002916.PUB2
Pleurodesis for malignant pleural effusions.
P. Shaw (2004)
10.1097/JTO.0b013e3181872764
Polyneuropathy in a patient with malignant pleural mesothelioma: a paraneoplastic syndrome.
C. Bech (2008)
10.1097/JTO.0b013e318200f447
The Use of Pleural Fluid sCD44v6/std Ratio for Distinguishing Mesothelioma from Other Pleural Malignancies
J. M. Porcel (2011)
10.1183/09031936.06.00013706
Thoracoscopy: general overview and place in the diagnosis and management of pleural effusion
F. Rodríguez-Panadero (2006)
10.1111/j.1440-1843.2011.01986.x
Pleural controversy: Pleurodesis versus indwelling pleural catheters for malignant effusions
P. Maceachern (2011)
10.1159/000327200
The Prevalence and Diagnostic Significance of Eosinophilic Pleural Effusions: A Meta-Analysis and Systematic Review
Y. Oba (2011)
10.1093/AJCP/72.1.48
Comparison of the diagnostic values of biopsies of the pleura and cytologic evaluation of pleural fluids.
B. Frist (1979)
10.1055/s-0030-1269834
Chylothorax and cholesterol pleural effusion.
J. T. Huggins (2010)
10.1378/CHEST.128.3.1431
Clinical efficacy and safety of thoracoscopic talc pleurodesis in malignant pleural effusions.
S. Kolschmann (2005)
10.1164/RCCM.200311-1579OC
Randomized trials describing lung inflammation after pleurodesis with talc of varying particle size.
N. Maskell (2004)
The value of multiple fluid specimens in the cytological diagnosis of malignancy.
L. W. Garcia (1994)
10.1007/s00408-011-9283-6
Tumor Type Influences the Effectiveness of Pleurodesis in Malignant Effusions
S. Bielsa (2011)
10.1378/CHEST.127.3.909
Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion.
C. Dresler (2005)
10.1016/S0720-048X(01)00426-0
Computed tomography features in malignant pleural mesothelioma and other commonly seen pleural diseases.
M. Metintas (2002)
10.1111/j.1440-1843.2007.01154.x
Diagnosis and management of malignant pleural effusions
J. Heffner (2008)
10.1016/j.lungcan.2009.08.019
Survival after trimodality therapy for malignant pleural mesothelioma: Radical Pleurectomy, chemotherapy with Cisplatin/Pemetrexed and radiotherapy.
S. Boeluekbas (2011)
10.1378/CHEST.107.6.1610
Changes in pulmonary mechanics and gas exchange after thoracentesis on patients with inversion of a hemidiaphragm secondary to large pleural effusion.
J. Wang (1995)
10.1016/j.arbres.2011.06.011
Eosinophilic pleural effusion: incidence, etiology and prognostic significance.
L. Ferreiro (2011)
10.1016/j.ccm.2006.01.003
Pleural ultrasonography.
P. Mayo (2006)
10.1016/S0140-6736(03)13079-6
Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial
N. Maskell (2003)
10.1023/B:BREA.0000010706.24181.b6
Malignant Pleural and Pericardial Effusion in Invasive Breast Cancer: Impact of the Site of the Primary Tumor
W. Pokieser (2004)
10.1136/pmj.77.908.407
An elderly man with pleural effusion and abnormal behaviour
A. Kashyap (2001)
10.1378/CHEST.130.4.1173
PRE- AND POSTTHORACENTESIS CHEST RADIOGRAPHIC FINDINGS DO NOT PREDICT ABNORMAL PLEURAL ELASTANCE
J. Heidecker (2006)
10.1002/cncr.23034
Accuracy of pleural biopsy using thoracoscopy for the diagnosis of histologic subtype in patients with malignant pleural mesothelioma
L. Greillier (2007)
10.1111/j.1440-1843.2009.01592.x
Pleural procedures and pleuroscopy
J. Wrightson (2009)
10.1016/j.athoracsur.2012.02.100
Treatment of malignant pleural effusion: a cost-effectiveness analysis.
V. Puri (2012)
10.2165/11594480-000000000-00000
Recent Developments in Treatment Stratification for Metastatic Breast Cancer
S. Barton (2012)



This paper is referenced by
Inducers of Epithelial Mesenchymal Transition and Cancer Stem Cells in Malignant Pleural Effusions
Cherubini Emanuela (2016)
10.1177/1753465815570307
Efficacy and safety profile of autologous blood versus tetracycline pleurodesis for malignant pleural effusion
W. Keeratichananont (2015)
10.21037/JTD.2019.06.44
Diagnostic value of CD206+CD14+ macrophages in diagnosis of lung cancer originated malignant pleural effusion.
Xue-Bin Pei (2019)
Diagnostic procedure in patients with neoplasm and malignant pleural effusion - our experience Diagnostyka nowotworu i nowotworowego wysięku opłucnowego - doświadczenia własne
G. Kacprzak (2012)
10.16966/2470-3176.126
Interventional Procedures for Management of Pleural Disorders
Kastelik Ja (2017)
Parámetros asociados a la eficacia de la pleurodesis y a la supervivencia en pacientes con derrame pleural maligno
Rocío Magdalena Díaz Campos (2015)
10.1016/J.JACC.2013.08.252
Prognostic Role of Incidental Pleural Effusion Diagnosed During Echocardiographic Evaluation
S. Ercan (2013)
10.1093/qjmed/hct245
Malignant pleural effusion.
A. Egan (2014)
10.1016/J.JASC.2015.01.009
Clinical presentation and cytopathologic features of malignant pericardial cytology: a single institution analysis spanning a 29-year period.
H. Zhu (2015)
10.1007/978-3-319-94127-1_7
Diseases of the Pleura
J. Kastelik (2018)
10.5761/atcs.oa.15-00230
Chemical Pleurodesis Using Mistletoe Extraction (ABNOVAviscum(®) Injection) for Malignant Pleural Effusion.
J. S. Cho (2016)
10.1007/s11427-016-0097-y
Interleukin-17 inhibits development of malignant pleural effusion via interleukin-9-dependent mechanism
Y. Lu (2016)
10.1016/j.thorsurg.2016.08.008
Indwelling Pleural Catheters: A Clinical Option in Trapped Lung.
Luca Bertolaccini (2017)
10.1016/J.EJCDT.2012.08.008
Fiberoptic thoracoscopy in management of exudative pleural effusion
M. A. Atta (2012)
10.1165/rcmb.2015-0396OC
Immune Regulation of Toll‐Like Receptor 2 Engagement on CD4+ T Cells in Murine Models of Malignant Pleural Effusion
X. Wu (2017)
10.1016/S1877-1203(14)70606-8
Abord de l’épanchement pleural métastatique symptomatique cas clinique interactif
Philippe Astoul (2014)
10.1620/tjem.242.137
Diagnostic Significance of Measuring Vascular Endothelial Growth Factor for the Differentiation between Malignant and Tuberculous Pleural Effusion.
Hak-Ryul Kim (2017)
10.1007/s13277-014-1795-2
Diagnostic accuracy of MOC-31 for malignant effusions: a meta-analysis
Diandian Li (2014)
The Frequency of Various Diseases in Patients Presenting with Pleural Effusion
M. Rehan (2013)
Effect of Betadine in chemical pleurodesis in patients with recurrent malignant pleural effusion between 2013 and 2015
Seyed Ziaoldin RasiHashemi (2017)
10.1007/s13277-012-0439-7
Evaluation of pleural fluid survivin and XIAP for the diagnosis of malignant pleural effusion
J. Li (2012)
10.1016/j.thorsurg.2019.08.003
Treatment of Pleural Effusions with Nonintubated Video-Assisted Thoracoscopic Surgery.
T. R. Qaqish (2020)
10.3332/ecancer.2014.424
Mistletoe preparation (Viscum Fraxini-2) as palliative treatment for malignant pleural effusion: a feasibility study with comparison to bleomycin
R. Gaafar (2014)
10.4103/2395-3977.163804
Palliative Treatment of Malignant Pleural Effusion
C. Liu (2015)
10.1007/978-3-319-21699-7_21
Diagnostic and Therapeutic Drainage
Samir K. Gadepalli (2016)
Efficacy of Povidone Iodine Induced Chemical Pleurodesis in Treatment of Patients with Recurrent Malignant Pleural Effusion between 2012-2014
Seyed Ziaeddin Rasi Hashemi (2018)
10.1183/20734735.018111
Palliative care in thoracic oncology
N. Schönfeld (2012)
10.3892/OL.2019.10383
Pleural fluid due to papillary thyroid cancer.
T. Tamura (2019)
10.3892/ETM.2016.3611
Increased soluble and membrane-bound PD-L1 contributes to immune regulation and disease progression in patients with tuberculous pleural effusion.
X. Pan (2016)
10.1016/j.canlet.2019.03.040
Macrophage-derived CCL22 promotes an immunosuppressive tumor microenvironment via IL-8 in malignant pleural effusion.
D. Wang (2019)
10.1117/12.2288386
Profiling pleural effusion cells by a diffraction imaging method
Safaa Al-qaysi (2018)
10.1016/j.cca.2017.12.003
Integrated semi-targeted metabolomics analysis reveals distinct metabolic dysregulation in pleural effusion caused by tuberculosis and malignancy.
Nanying Che (2018)
See more
Semantic Scholar Logo Some data provided by SemanticScholar